CD80 and hepatocellular carcinoma: In particular, Beckebaum et al. [178] observed that HCC patients were characterized by a reduction in circulating pDCs and both cDC subsets, cDC1s and cDC2s; moreover, all circulating DC subsets exhibited lower expression of HLA-DR and costimulatory molecules CD80 and CD86.